These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9008022)

  • 1. N-acetyl-beta-D-glucosaminidase excretion in calcium oxalate stone patients and its relation to the risk of stone formation.
    Winter P; Ganter K; Heimbach D; Hesse A
    Scand J Urol Nephrol; 1996 Dec; 30(6):439-43. PubMed ID: 9008022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis.
    Balla AA; Salah AM; Abdalmotaal E; Hoppe B; Bongartz D; Kessler T; Hesse A
    World J Urol; 1998; 16(6):413-6. PubMed ID: 9870291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.
    Sikora P; Glatz S; Beck BB; Stapenhorst L; Zajaczkowska M; Hesse A; Hoppe B
    Pediatr Nephrol; 2003 Oct; 18(10):996-9. PubMed ID: 12920632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular impairment in children with idiopathic hypercalciuria.
    Skálová S; Kutílek S
    Acta Medica (Hradec Kralove); 2006; 49(2):109-11. PubMed ID: 16956119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis.
    Baggio B; Gambaro G; Ossi E; Favaro S; Borsatti A
    J Urol; 1983 Jun; 129(6):1161-2. PubMed ID: 6133962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
    Huang HS; Ma MC; Chen CF; Chen J
    Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
    Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
    Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.
    Prochaska M; Taylor E; Ferraro PM; Curhan G
    J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does sucrose damage kidneys?
    Li MK; Kavanagh JP; Prendiville V; Buxton A; Moss DG; Blacklock NJ
    Br J Urol; 1986 Aug; 58(4):353-7. PubMed ID: 3756399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.